GENEVA, Sept. 18 -- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. filed a patent application (CN2026/081030) for “TL1A/IL-23 BINDING PROTEIN AND PHARMACEUTICAL USE THEREOF”. With publication no. WO/2026/184568, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/24
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....